Company intelligence / Profile preview

Soluble Biotech

Birmingham, Alabama, United States

Ownership: Private
Development stage: Other

Overview

Soluble Biotech is a platform biotechnology company and Contract Research Organization (CRO) specializing in optimizing protein therapeutic formulations for solubility and stability. Using proprietary self-interaction chromatography and AI/ML technologies, the company offers contract services to pharmaceutical and biotech companies developing protein-based therapeutics. It was acquired by Predictive Oncology in 2020.

Modalities: ProteinRecombinant proteinAntibodyVaccineHormone
Industry: Drug Discovery Services

Partnerships

Multiple contracts with large pharmaceutical companiesCystic Fibrosis Foundation

Beyond the preview

Go deeper on Soluble Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soluble Biotech.

Explore the full profile